RxDoctor Payments Data

Jeanna Berkey, PA

Physician Assistant · Laurel, MSNPI 1891400578

Payments from drug & device makers

$998in general payments, 2019–2025

Across 54 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$267
  • Novo Nordisk$204
  • AbbVie$146
  • Amgen$74
  • Averitas Pharma Inc.$74
  • Bayer$69
  • plus $164 from 10 others

What the payments were for

  • Food & beverage$998100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$998 in reported general payments places this provider in the 55th percentile of 278 physician assistant providers in Mississippi.

See all physician assistant providers in Mississippi

Medicare billing

Part B allowed, 2024
$468
Medicare patients
61
Services billed
91

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin81$78,959
OzempicSemaglutide57$71,368
FarxigaDapagliflozin Propanediol40$48,760
EliquisApixaban57$47,263
MounjaroTirzepatide23$30,589
TrulicityDulaglutide18$23,383
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$16,677
LinzessLinaclotide24$12,300
XareltoRivaroxaban13$10,084
JanuviaSitagliptin Phosphate12$6,377
Potassium Chloride95$2,946
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,227
Gabapentin154$1,937
Duloxetine Hcl72$1,747
LantusInsulin Glargine,hum.Rec.Anlog12$1,655

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$16$78,95981 claims
Novo NordiskOzempic$204$71,36857 claims
Lilly USA, LLCMounjaro, Trulicity$267$53,97241 claims
AstraZenecaFarxiga$15$48,76040 claims
PfizerEliquis$14$47,26357 claims
GSKTrelegy Ellipta$17$16,67721 claims
AbbVieLinzess$146$12,30024 claims
Johnson & JohnsonXarelto$22$10,08413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 278 physician assistant providers in Mississippi.

Other physician assistant in Laurel

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →